Ultrasound-actuated drug delivery with acoustic percolation switches

Maria Paulene Abundo,Anna T Tifrea,Marjorie T Buss,Pierina Barturen-Larrea,Zhiyang Jin,Dina Malounda,Mikhail G. Shapiro

DOI: https://doi.org/10.1101/2024.05.10.593654

2024-05-14

Abstract:Devices that can be remote-controlled under image guidance to precisely deliver biomedicines to sites of disease are a major goal of biomedical research. However, most existing externally triggered delivery systems are based on complex micromachines that are controlled with electromagnetic waves and require custom external instrumentation. Here we present a drug delivery platform comprising a simple protein-containing hydrogel that can be both imaged and triggered to release drugs at specific locations using widely available ultrasound imaging devices. This technology is based on the addition of air-filled protein nanostructures called gas vesicles (GVs) to hydrogel delivery vehicles. While intact, GVs sterically block the release of drug payloads and allow the vehicle to be imaged with ultrasound. An increase in ultrasound pressure causes the collapse of GVs within hydrogels present at the desired anatomical location, instantly creating percolation channels and triggering rapid drug release. Both the imaging and release are performed using a common diagnostic ultrasound probe. We implement this concept by establishing ultrasound-controlled drug diffusion and release from hydrogels in vitro and demonstrating targeted image-guided protein delivery in vivo following oral administration. We use this approach to deliver anti-inflammatory antibodies to treat gastrointestinal inflammation in a rat model of colitis. Targeted acoustic percolation switches (TAPS) open a conduit for local, image-guided drug delivery with a simple formulation and commonplace ultrasound equipment.

Bioengineering

What problem does this paper attempt to address?

The main objective of this paper is to develop a novel drug delivery system that can be precisely controlled remotely through ultrasound imaging to achieve targeted drug administration to disease sites. The authors propose a hydrogel platform based on gas vesicles (GVs), which can serve both as an ultrasound imaging contrast agent and as a triggerable drug release system at specific locations.

Specifically, the study addresses the following key issues:
1. **Remote Control of Drug Delivery**: In existing technologies, most externally triggered delivery systems rely on complex micromechanical devices that usually require custom external instruments and are difficult to focus in vivo. Light-based triggering systems are limited by tissue penetration.
2. **Utilizing Ultrasound Technology**: The research team proposes a simple method using diagnostic ultrasound equipment to track and trigger drug delivery carriers. This allows for image-guided drug delivery using widely available, low-cost instruments.
3. **Role of Gas Vesicles**: The study uses gas vesicles extracted from planktonic photosynthetic microorganisms, which can form air-filled nanostructures (GVs). When intact, GVs can prevent drug diffusion and allow the carrier to be visualized through ultrasound imaging; when ultrasound pressure increases, GVs collapse at the desired anatomical location, rapidly releasing the drug.
4. **In Vivo Application Validation**: The research not only validated the effectiveness of this method in vitro but also demonstrated in a rat model the effect of delivering anti-inflammatory antibodies to the gastrointestinal tract through oral administration and ultrasound activation, thereby treating experimental colitis.

In summary, this study introduces "Targeted Acoustic Percolation Switches" (TAPS) to achieve localized, image-guided drug delivery using simple formulations and common ultrasound equipment. This approach is expected to simplify the drug delivery process, enhance therapeutic efficacy, and reduce side effects.